Total Funding
1
Total FundingPrivate Equity raised
Growth Score
pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
496819
Theracos Inc., a pharmaceutical research and development company, supports research programs in inflammation, metabolism and depression.
Albert R. Collinson: President & CEO
About the Company
Theracos, Inc. is a privately held pharmaceutical research and development company located in Marlborough, Massachusetts. The company was founded in 2000 with the mission to develop novel therapeutic agents for diseases with significant unmet medical need. It is currently conducting development of multiple programs in human clinical testing.
Theracos is well positioned to accomplish its development and commercialization objectives due to its understanding of the marketplace and its network of partners. The company has a strong advisory team in toxicology, formulation development, QA/QC, regulatory, clinical, and trial design and execution. The team members have over 10-20 years of experience each in their areas of expertise.
